TNDM Tandem Diabetes Care Inc

Price (delayed)

$41.02

Market cap

$2.65B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.17

Enterprise value

$3.07B

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights
Tandem Diabetes Care's EPS has increased by 37% from the previous quarter and by 31% YoY
The net income has increased by 36% from the previous quarter and by 31% YoY
Tandem Diabetes Care's gross profit has decreased by 6% YoY but it has increased by 3.2% from the previous quarter
TNDM's revenue is down by 3.1% year-on-year but it is up by 3% since the previous quarter
The company's equity fell by 28% YoY and by 23% QoQ
Tandem Diabetes Care's quick ratio has decreased by 18% YoY

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
64.59M
Market cap
$2.65B
Enterprise value
$3.07B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
11.08
Price to sales (P/S)
3.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.98
Earnings
Revenue
$770.01M
EBIT
-$126.05M
EBITDA
-$109.69M
Free cash flow
-$43.91M
Per share
EPS
-$2.17
Free cash flow per share
-$0.67
Book value per share
$3.7
Revenue per share
$11.79
TBVPS
$14.41
Balance sheet
Total assets
$941.05M
Total liabilities
$697.98M
Debt
$477.55M
Equity
$243.06M
Working capital
$542.22M
Liquidity
Debt to equity
1.96
Current ratio
3.81
Quick ratio
2.91
Net debt/EBITDA
-3.82
Margins
EBITDA margin
-14.2%
Gross margin
49.3%
Net margin
-18.4%
Operating margin
-19.1%
Efficiency
Return on assets
-15%
Return on equity
-47.2%
Return on invested capital
-11.4%
Return on capital employed
-16.9%
Return on sales
-16.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-3.64%
1 week
-3.75%
1 month
2.17%
1 year
22.48%
YTD
38.67%
QTD
1.81%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$770.01M
Gross profit
$379.46M
Operating income
-$147.09M
Net income
-$141.45M
Gross margin
49.3%
Net margin
-18.4%
The operating margin has grown by 39% from the previous quarter and by 26% YoY
The net margin has increased by 38% from the previous quarter and by 28% YoY
The operating income rose by 37% QoQ and by 28% YoY
The net income has increased by 36% from the previous quarter and by 31% YoY

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
11.08
P/S
3.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.98
Tandem Diabetes Care's EPS has increased by 37% from the previous quarter and by 31% YoY
TNDM's price to book (P/B) is 85% more than its last 4 quarters average of 6.2 but 18% less than its 5-year quarterly average of 14.0
The company's equity fell by 28% YoY and by 23% QoQ
The P/S is 57% higher than the last 4 quarters average of 2.3 but 55% lower than the 5-year quarterly average of 8.0
TNDM's revenue is down by 3.1% year-on-year but it is up by 3% since the previous quarter

Efficiency

How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has increased by 42% from the previous quarter and by 33% YoY
The return on invested capital has increased by 41% since the previous quarter and by 33% year-on-year
The return on assets has increased by 36% since the previous quarter and by 25% year-on-year
TNDM's ROE is up by 31% from the previous quarter and by 4.5% YoY

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 35% greater than the total liabilities
Tandem Diabetes Care's quick ratio has decreased by 18% YoY
TNDM's current ratio is down by 14% year-on-year
The debt is 96% more than the equity
The company's debt to equity has surged by 58% YoY and by 47% QoQ
The company's equity fell by 28% YoY and by 23% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.